A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Induction and Monitoring of Adoptive Delayed-Type Hypersensitivity in Rats

10.9K views

DOI:

10.3791/325

October 1st, 2007

In This Article

Summary

Delayed type hypersensitivity (DTH) is an inflammatory reaction mediated by CCR7- effector memory T (TEM) lymphocytes. Here we demonstrate how to activate antigen-specific TEM cells, induce adoptive DTH in Lewis rats and monitor the inflammatory response.

Abstract

Delayed type hypersensitivity (DTH) is an inflammatory reaction mediated by CCR7- effector memory T lymphocytes that infiltrate the site of injection of an antigen against which the immune system has been primed. The inflammatory reaction is characterized by redness and swelling of the site of antigenic challenge. It is a convenient model to determine the in vivo efficacy of immunosuppressants. Cutaneous DTH can be induced either by adoptive transfer of antigen-specific T lymphocytes or by active immunization with an antigen, and subsequent intradermal challenge with the antigen to induce the inflammatory reaction in a given skin area. DTH responses can be induced to various antigens, for example ovalbumin, tuberculin, tetanus toxoid, or keyhole limpet hemocyanin. Such reactions can also be induced against autoantigen, for example to myelin basic protein (MBP) in rats with experimental autoimmune encephalomyelitis induced with MBP, an animal model for multiple sclerosis (1). Here we demonstrate how to induce an adoptive DTH reaction in Lewis rats. We will first stimulate ovalbumin-specific T cells in vitro and inject these activated cells intraperitoneally to naive rats. After allowing the cells to equilibrate in vivo for 2 days, we will challenge the rats with ovalbumin in the pinna of one ear, while the other ear wil receive saline. The inflammatory reaction will be visible 3-72 hours later and ear thickness will be measured as an indication of DTH severity.

Protocol

1. Stimulation of the ovalbumin-specific T lymphocytes

Resting ovalbumin-specific T cells are stimulated with ovalbumin in the presence of irradiated Lewis rat thymocytes (30 Gy) as antigen presenting cells (APCs), in Stimulation Medium (Prepare in DMEM + Pen/Strep/L-Glut + NEAA + RPMI Vitamins + 2ME + Rat Serum + Ovalbumin, at the final concentrations noted in the materials list.)

Rat serum preparation

  1. We take serum from the rats we sacrifice as thymus donors.
  2. Rats are deeply anesthetized by halothane inhalation and as much blood as possible is drawn by cardiac perfusion (5-10 ml per rat) using ....

Access restricted. Please log in or start a trial to view this content.

Discussion

The antigenic challenge can also be performed at other sites, for example in the skin of the back (2). We however find that challenging. Using the pinna of the ear, as shown in this video, allows for the most precise measurement of the DTH reaction.

....

Access restricted. Please log in or start a trial to view this content.

Acknowledgements

We thank Dr. Alexander Flugel (Martinsried, Germany) for providing us with the GFP-labeled, ovalbumin-specific T cell line used in this protocol.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
DMEMGIBCO, by Life Technologies12430-062500ml
Sodium pyruvateSigma-AldrichS86361 mM final, in Stimulation medium
Penicillin – Streptomycin – L-GlutamineCambrex/BioWhittaker17-718R100 u/ml - 100 μg/ml - 4 mM respectively, final, in Stimulation Medium
Non essential amino acidsSigma-AldrichR7131NEAA, 1% final, in Stimulation Medium
RPMI vitaminsSigma-AldrichR72561% final, in Stimulation medium
beta-mercapt–thanolSigma-AldrichM62502ME, 50 μM final, in Stimulation Medium
Syngeneic rat serum1% final. See explanation in Protocol.
OvalbuminSigma-AldrichA550310 μg/ml final, in Stimulation Medium.

References

  1. Beeton, C., Barbaria, J., Devaux, J., Benoliel, A. -M., Gola, M., Sabatier, J. -M., Bernard, D., Crest, M., Beraud, E. Selective blocking of voltage-gated K+ channels treats experimental autoimmune encephalomyelitis and inhibits T-cell activation. J. Immunol. , 166-936 (2001).
  2. Beeton, C., Chandy, K. G.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

T Cell ActivationAntigen Specific T CellsOvalbumin ChallengeEar Thickness MeasurementStromal Vascular FractionFlow CytometryConfocal MicroscopyWestern BlotCell Isolation